In a PC setting, GOLD I and II patients also showed a trend to improving trough FEV1 with tiotropium compared with placebo after 12 weeks [effect size 40 ml (95%CI -30, 100)] [ 62 ].
← all excerpts
What have we learned from observational studies and clinical trials of mild to moderate COPD?
1
—
—